These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6195845)

  • 1. [Mechanisms of protection in the pathogenesis of the typhoid bacterial carrier state].
    Obgol'ts AA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Aug; (8):98-103. PubMed ID: 6195845
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of the typhoid bacterium carrier state].
    Obgol'ts AA; Dalmatov DM
    Sov Med; 1986; (4):54-7. PubMed ID: 3520873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunobiological aspects of the typhoid bacteria carrier state (a review of the literature)].
    Bilibin AF; Khundanov LL
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Nov; (11):9-17. PubMed ID: 4615523
    [No Abstract]   [Full Text] [Related]  

  • 4. Typhoid fever: pathogenesis and immunologic control.
    Hornick RB; Greisman SE; Woodward TE; DuPont HL; Dawkins AT; Snyder MJ
    N Engl J Med; 1970 Sep; 283(13):686-91. PubMed ID: 4916913
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenetic problems of the typhoid fever bacterial carrier state].
    Il'inskiĭ IuA; Bondarenko VM; Pogorel'skaia LV; Marchenko VG
    Sov Med; 1980; (9):74-9. PubMed ID: 7423267
    [No Abstract]   [Full Text] [Related]  

  • 6. Investigation of the role of Vi antibodies and antibodies of IgA type in the low specific bactericidal activity of the serum in typhoid carriers.
    Karolcek J; Draskovicová M; Ciznár I
    Zentralbl Bakteriol Orig A; 1975 Jul; 232(2-3):247-51. PubMed ID: 1179883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of Vi-antibody formation in typhoid fever and chronic typhoid fever bacterial carriers].
    Karmanov MI
    Sov Med; 1973 May; 36(5):149-50. PubMed ID: 4768336
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results and prospects of a study of the bacterial carrier state in typhoid].
    Bilibin AF; Khundanov LL
    Vestn Akad Med Nauk SSSR; 1975; (2):53-9. PubMed ID: 1179838
    [No Abstract]   [Full Text] [Related]  

  • 9. Study on the production of IgG, IgA- and IgM-antibodies to somatic antigens of Salmonella typhi in humans.
    Chernokhvostova E; Luxemburg KI; Starshinova V; Andreeva N; German G
    Clin Exp Immunol; 1969 Apr; 4(4):407-21. PubMed ID: 4182404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shedding light on Salmonella carriers.
    Gopinath S; Carden S; Monack D
    Trends Microbiol; 2012 Jul; 20(7):320-7. PubMed ID: 22591832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative evaluation of the dynamics of physico-chemically different serum O- and K-antibodies in typhoid and chronic typhoid carriers].
    Bunin KV; Tokarenko LG; Kravtsov EG
    Zh Mikrobiol Epidemiol Immunobiol; 1981 Apr; (4):67-9. PubMed ID: 7269903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of O and H agglutinins for S. typhi in healthy school children 5-11 years: a cross sectional survey.
    Deivanayagam N; Devikumari DV
    Indian Pediatr; 1991 Apr; 28(4):420-1. PubMed ID: 1721606
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathogenetic and immunological characteristics of different forms of the Salmonella typhi carrier state].
    Obgol'ts AA; Kononov AV; Konev VP
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):71-6. PubMed ID: 3604512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cross-reacting antigens of Opisthorchis felineus and Salmonella typhi and their possible effect on the clinical course of typhoid fever].
    Lepekhin AV; Ratner GM; Meniavtseva TA
    Med Parazitol (Mosk); 1990; (4):33-6. PubMed ID: 2233535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization reaction of bacteriolysins and its application for the titration of salmonella O antigens.
    Tendetnik YY; Levi MI; Rukhadze EZ; Vydrina EI; Pryamukhina NS
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):104-13. PubMed ID: 4575461
    [No Abstract]   [Full Text] [Related]  

  • 16. Selective primary health care: strategies for control of disease in the developing world. XX. Typhoid fever.
    Hornick RB
    Rev Infect Dis; 1985; 7(4):536-46. PubMed ID: 2412272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The function of Salmonella typhi at different stages in the pathogenesis of typhoid infection].
    Obgol'ts AA; Demidova AD; Rogatykh NA; Gasheva AZ
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Jun; (6):66-71. PubMed ID: 3307243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenesis of the typhoid bacteria carrier state].
    Bilibin AF; Lashin VIa; Markova EA; Khundanov LL
    Sov Med; 1976; (5):8-13. PubMed ID: 968618
    [No Abstract]   [Full Text] [Related]  

  • 19. [A study of the avidity of Vi antibodies in typhoid fever patients and chronic carriers].
    Bunin KV; Firsanov VI; Kravtsov EG; Sukhoroslova LI; Kapuka LP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Oct; (10):65-9. PubMed ID: 1007716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.